Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosis
Makaleler > Tam Makale · 2015
Yazarlar: Suleyman KARAKÖSE, Nevin ORUÇ, Melia ZENGİN, Ulus Salih AKARCA, Galip ERSÖZ
TURKISH JOURNAL OF GASTROENTEROLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2015, cilt 26, ss 42-48
Özet
Background/Aims: The diagnosis of an underlying myeloproliferative neoplasm (MPN) is often problematic in patients with Budd Chiari syndrome (BCS) or portal vein thrombosis (PVT). This study aimed to assess the diagnostic value of the JAK2 gene V617F gain-of-function mutation for MPN in splanchnic vein thrombosis patients.